Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The $500M initial Sanofi payment is due Monday, May 20. We should see a PR and/or SEC 8-K filing this week.
I expect news of additional partnerships or licensing agreements for Matrix-M adjuvant over the coming weeks and months.
As more people listen to the Novavax presentation at the Bank of America 2024 Healthcare Conference, there will be more new investors buying in for the first time, and current investors adding to their existing positions. I expect to see NVAX share price climb higher. We'll get news updates in between earnings that will add fuel to the fire. I don't believe Sanofi is going to be the only partner we sign this year. Another partner with a similar up-front cash and royalty deal will light the fuse on the second rocket engine, with the first rocket engine ignited by the Sanofi deal. Great time to be a NVAX shareholder.
Total Calls i meant
total call 150, will add some tomorrow, if stocks break day high of today
I have $19 Calls also this can run ugly upside since highest short interest and borrowing fee
The BoA conference presentation yesterday is really worth a listen. The BoA analyst did a great job with the questions and investors learned more about the incredible benefits of the Sanofi partnership. I feel fortunate to be an investor here.
Webcast link
May 2024 Investor Presentation - Not part of BoA presentation but recommended
Let’s see here. May base and then rip to +19. Calls are going to pay
+70k. Out till pull back. Daily over parabolic
? why doesn't NVAX show on the Breakout board?
I would love for that to happen...
Wish I had bought more
Today's Sanofi partnership news and subsequent rise in share price likely generated a significant number of margin calls for shorts. Demand for shares should be pretty high next week to cover today's margin calls. Any movement higher will generate even more margin calls. Great time for a big short squeeze. Thanks shorties for the cheap shares I was able to pick up over the last few months.
NVAX
Novavax Inc
8.93
4.45 (99.33%)
Volume: 170,708,691
Day Range: 8.61 - 11.00
Bid: 8.93
Ask: 8.95
Last Trade Time: 7:11:59 PM EDT
Total Trades: 892,437
Added another 550 shares, now at 17,700 @ $5.32 average cost.
Exciting times ahead for Novavax. Looking forward to seeing what this Sanofi partnership brings to shareholders.
Nice. 10 large her at $7. Follow VWAP
NVAX: Even Global REUTERS can barely handle the EXPANSIVE news still coming-out!! (More just out, below!!)
"BRIEF-Novavax Exec Says Now Anticipate Data Readouts For Both Novavax's Combination Covid-Flu Shot And Standalone Flu Vaccine In Mid 2025"
Same here. 17,150 shares at average cost of $5.17. The partnership announced today negates all of Shah's concerns. I'm revising my votes.
NVAX: This news was SPLATTERED across the entire Planet today, by every conceivable Global News Service. A FRENCH Firm partnership, bringing-in the entire European Union interest here. Then toss-in the USA, Canada, & Western Hemisphere, to boot. Not even to mention monster ASIA & the British Commonwealth. Talk about a potential, a REAL, a COLLOSAL health care MARKET PLACE!!! (And a stock PRICE this incredibly CHEAP???!!! Are you frickin' kidding me???)
thanks for the news.... good news at last... I'm in profit here... love the colour green....
NVAX: This news today goes far, far, BEYOND a simple Covid vaccine deal, Folks!!! Call me straight-up BONKERS, if you like, but this could very well become the Wall Street EXPLOSION of this frickin' YEAR 2024!!!
"Oh, Harry, what in God's name was THAT???!!! --- Fret not, Honey, it was just our NVAX stock investment taking-off on Wall Street today."
//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
NVAX: Notwithstanding shares count, shorting, float, inter alia, this puppy could nonetheless be a 10-bagger today, from yesterday's Close. (If I prove to be pathetically STUPID in my prognostication here, well, you can see ME, below, fully admitting just 15-minutes ago my overall Wall Street 'acumen', generally.)
CONGRAT$ ON THAT CALL
AMA
Monday, May 06, 2024 11:18:18 AM👈️
NVAX in Play. Big move coming...
Major Developments
5/10/2024, 6:06:45 AMLicensing deal with Sanofi, $500m upfront and $700m for development.
https://dilutiontracker.com/app/search/NVAX
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
https://finance.yahoo.com/news/sanofi-inks-1-2-billion-082615895.html
JUST IN: Huge news from #Novavax ( $NVAX) as they announce a game-changing $1.4 billion deal with Sanofi ( $SNY) 🚀🔬
— Antonio Santiago (@awsan) May 10, 2024
💸 Partnership Perks:
Sanofi to invest $500M upfront, promising another $700M for hitting key milestones. Plus, an additional $200M to adopt Novavax’s Matrix-M… pic.twitter.com/MpqMqePkcd
Doesn’t look like at 7:45
Went up too high too fast
33% short in Finviz on 130m float. That’s a lot shares
imo...have you guys tried the new hand sanitizer...? .....talk about delicious~ NVAX
NVAX
IHuser
NVAX
Novavax Inc
5.1192
-0.0108 (-0.21%)
Volume: 4,050,875
Day Range: 4.98 - 5.2187
Last Trade Time: 6:11:12 PM EDT
Delayed by 15 minutes
yes, sold a few for a good little profit thank goodness then the sell off today. Grabbed a few during the melee. Looking good for this year IMO.
ascending pennant,cup and handle forming,this could be the make or break moment here,stop loss set 5.18(my in),its been steady distribution since hod,not looking good with vol fading also,no vol surges either,beating shorts is 1 in a million
weekly,monthly charts bullish,currently higher lows and highs,52M shares have to be covered in 8.7 days(they have to cover some time,but will they,dang mm/bank criminals)
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
https://ir.novavax.com/press-releases/2024-02-20-Novavax-to-Host-Conference-Call-to-Discuss-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Operational-Highlights-on-February-28,-2024
Schedule 13G issued for Morgan Stanley 6.2% ownership (7.3M) shares of NVAX.
SEC Filing
Followers
|
338
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8533
|
Created
|
06/19/03
|
Type
|
Free
|
Moderators mick JoeForkeyBolo |
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases.
Using innovative proprietary recombinant nanoparticle vaccine technology,
we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...
INVESTORS
Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease. More...
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |